Patents by Inventor Angel Guzman-Perez

Angel Guzman-Perez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sodium-hydrogen exchanger type 1 inhibitor
    Patent number: 6852733
    Abstract: NHE-1 inhibitor, methods of using the NHE-1 inhibitor and pharmaceutical compositions containing the NHE-1 inhibitor. The NHE-1 inhibitor is useful for the reduction of tissue damage resulting from tissue ischemia.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: February 8, 2005
    Assignee: Pfizer Inc.
    Inventors: Weichao G. Chen, Eric D. Cox, Angel Guzman-Perez
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050020604
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: August 19, 2004
    Publication date: January 27, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch, Angel Guzman-Perez, Paul DaSilva-Jardine, Ravi Garigipati, Kevin Liu
  • N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
    Publication number: 20030149043
    Abstract: NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.
    Type: Application
    Filed: December 9, 2002
    Publication date: August 7, 2003
    Applicant: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, Angel Guzman-Perez, Christian J. Mularski, Roger B. Ruggeri, Ronald T. Wester
  • 5-HT receptor ligands and uses thereof
    Publication number: 20030125334
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: June 5, 2002
    Publication date: July 3, 2003
    Inventors: Phoebe Chiang, William A. Novomisle, Willard M. Welch, Angel Guzman-Perez, Paul A. DaSilva-Jardine, Ravi S. Garigipati, Kevin K. Liu
  • N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
    Patent number: 6492401
    Abstract: NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.
    Type: Grant
    Filed: August 18, 1999
    Date of Patent: December 10, 2002
    Assignee: Pfizer, Inc.
    Inventors: Ernest S. Hamanaka, Angel Guzman-Perez, Roger B. Ruggeri, Ronald T. Webster, Christian J. Mularski
  • Sodium-hydrogen exchanger type 1 inhibitor
    Publication number: 20010051634
    Abstract: NHE-1 inhibitor, methods of using the NHE-1 inhibitor and pharmaceutical compositions containing the NHE-1 inhibitor. The NHE-1 inhibitor is useful for the reduction of tissue damage resulting from tissue ischemia.
    Type: Application
    Filed: April 17, 2001
    Publication date: December 13, 2001
    Inventors: Weichao G. Chen, Eric D. Cox, Angel Guzman-Perez